At the TSANZ 2024 annual meeting, Dr Sanjay Ramakrishnan discussed the implications for biomarker-guided treatment of COPD exacerbations based on results from the STARR2 study.
2 Apr 2024
At the TSANZ 2024 annual meeting, Dr Sanjay Ramakrishnan discussed the implications for biomarker-guided treatment of COPD exacerbations based on results from the STARR2 study.